These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 7940824)
1. Lovastatin treatment of hyperlipidemia in kidney transplant recipients on cyclosporine immunosuppression. Kandus A; Kovac D; Koselj M; Kveder R; Bren AF Transplant Proc; 1994 Oct; 26(5):2642-3. PubMed ID: 7940824 [No Abstract] [Full Text] [Related]
2. Low-dose lovastatin in hyperlipidemic kidney graft recipients with cyclosporine A. Traindl O; Reading S; Franz M; Falger S; Klauser R; Gisinger J; Widhalm K; Kovarik J Transplant Proc; 1992 Dec; 24(6):2745-7. PubMed ID: 1465924 [No Abstract] [Full Text] [Related]
3. Comparison of pravastatin and lovastatin in renal transplant patients receiving cyclosporine. Kliem V; Wanner C; Eisenhauer T; Olbricht CJ; Doll R; Boddaert M; O'Grady P; Krekler M; Mangold B; Christians U Transplant Proc; 1996 Dec; 28(6):3126-8. PubMed ID: 8962211 [No Abstract] [Full Text] [Related]
4. Effect of lovastatin and bezafibrate on cyclosporine-induced hyperlipidemia in rabbits. Hidalgo L; López-Miranda J; Espino A; Alcala J; Blanco J; Prada JL; Rodríguez M; Jiménez-Perepérez JA; Jansen S; Pérez-Jiménez F Transplant Proc; 1995 Apr; 27(2):1857-61. PubMed ID: 7725532 [No Abstract] [Full Text] [Related]
5. Effect of pravastatin on renal transplant recipients treated with cyclosporine--4-year follow-up. Yoshimura N; Ohmori Y; Tsuji T; Oka T Transplant Proc; 1994 Oct; 26(5):2632-3. PubMed ID: 7940820 [No Abstract] [Full Text] [Related]
6. Dislipidemia at different immunosuppressive protocols. Zezina L; Rosental R Transplant Proc; 1994 Dec; 26(6):3223. PubMed ID: 7998123 [No Abstract] [Full Text] [Related]
7. Vitamin E in kidney transplantation: effect of treatment with simvastatin in hypercholesterolemia. Cantarell C; Bonal J; Sierra C; Pastor C; Lauzurica R; Capdevila L Transplant Proc; 1995 Aug; 27(4):2222-3. PubMed ID: 7652781 [No Abstract] [Full Text] [Related]
8. Impact of fluvastatin on hyperlipidemia after renal transplantation. Tokumoto T; Tanabe K; Ishida H; Shimmura H; Ishikawa N; Goya N; Akiba T; Toma H Transplant Proc; 2004 Sep; 36(7):2141-4. PubMed ID: 15518777 [TBL] [Abstract][Full Text] [Related]
9. Therapy of hyperlipidemia with lovastatin in kidney transplant patients on cyclosporine A immunosuppression: three-year experience. Kandus A; Kovac D; Cerne D; Koselj M; Kaplan-Pavlovcic S; Buturović J; Ponikvar R; Kveder R; Lindic J; Bren AF Transplant Proc; 1998 Jun; 30(4):1307-9. PubMed ID: 9636530 [No Abstract] [Full Text] [Related]
10. Serum lipoproteins in renal transplant patients: the effect of cyclosporine on lipoprotein(a). Süleymanlar G; Ozben T; Sapan M; Yìlmaz H; Yakupoglu G; Karpuzoglu T Transplant Proc; 1994 Oct; 26(5):2637-8. PubMed ID: 7940822 [No Abstract] [Full Text] [Related]
11. Renal function and lipid metabolism in pregnant renal transplant recipients. Czajkowski K; Wójcicka-Bentyn J; Sieńko J; Grymowicz M; Smolarczyk R; Malinowska-Polubiec A; Romejko E Eur J Obstet Gynecol Reprod Biol; 2004 Jun; 114(2):155-61. PubMed ID: 15140508 [TBL] [Abstract][Full Text] [Related]
12. Effect of pravastatin in the treatment of hypercholesterolemia after renal transplantation under cyclosporine and prednisone. Castelao AM; Grinyó JM; Castiñeiras MJ; Fiol C; Gilvernet S; Seron D; Torras J; Cruzado JM; Alsina J Transplant Proc; 1995 Aug; 27(4):2217-20. PubMed ID: 7652779 [No Abstract] [Full Text] [Related]
13. Lipid profile in renal transplant recipients under various immunosuppressive regimens. Montagnino G; Tarantino A; Aroldi A; Banfi G; Cesana B; Ponticelli C Transplant Proc; 1994 Oct; 26(5):2634-6. PubMed ID: 7940821 [No Abstract] [Full Text] [Related]
17. Lipid profiles in pediatric thoracic transplant recipients are determined by their immunosuppressive regimens. Law YM; Yim R; Agatisa P; Boyle GJ; Miller SA; Lawrence K; Webber SA J Heart Lung Transplant; 2006 Mar; 25(3):276-82. PubMed ID: 16507419 [TBL] [Abstract][Full Text] [Related]
18. Relative effectiveness of niacin and lovastatin for treatment of dyslipidemias in a health maintenance organization. O'Connor PJ; Rush WA; Trence DL J Fam Pract; 1997 May; 44(5):462-7. PubMed ID: 9152263 [TBL] [Abstract][Full Text] [Related]
19. Dyslipidemia during sirolimus therapy in liver transplant recipients occurs with concomitant cyclosporine but not tacrolimus. Trotter JF; Wachs ME; Trouillot TE; Bak T; Kugelmas M; Kam I; Everson G Liver Transpl; 2001 May; 7(5):401-8. PubMed ID: 11349259 [TBL] [Abstract][Full Text] [Related]
20. Effect of oral fructose load on serum uric acid and lipids in kidney transplant recipients treated with cyclosporine or tacrolimus. Zawiasa A; Szklarek-Kubicka M; Fijałkowska-Morawska J; Nowak D; Rysz J; Mamełka B; Nowicki M Transplant Proc; 2009; 41(1):188-91. PubMed ID: 19249511 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]